Medaphor Group PLC ScanNav AI software featured on ITV

TIDMMED

Medaphor Group PLC

14 May 2018

MedaPhor Group plc

("MedaPhor" or the "Group" or the "Company")

ScanNav AI software featured on ITV

MedaPhor Group plc (AIM: MED), the intelligent ultrasound software and simulation company, announces its artificial intelligence ("AI") based real-time image analysis software, ScanNav(TM) has featured on the ITV 'Wales This Week' programme.

ScanNav uses deep learning-based algorithms to automatically identify, grade and capture good ultrasound images to provide real-time guidance, assessment and audit of obstetric scanning. It is believed to be the first AI system to carry out an automated, real-time "peer review" of obstetric ultrasound images as the patient is scanned.

The technology is currently being piloted at the Fetal Medicine Department of St George's University Hospitals NHS Trust in London, UK.

Nicholas Sleep, Chief Technology Officer at MedaPhor, commented: "The initial feedback from the pilot of our ScanNav AI software in St George's Hospital, London has been very positive. After expanding the pilot over the coming months, we look forward to ScanNav being used more widely to improve ultrasound scanning for patients."

The feature is available to view on the Company website here: https://www.medaphor.com/tomorrows-ai-ultrasound-technology-is-here-scannav-debuts-on-itv-news/

Enquiries:

 
 MedaPhor Group plc                                                               www.medaphor.com 
 Stuart Gall, CEO                                                         Tel: [phone] 
  Ian Whittaker, COO 
 
 Cenkos Securities                                                        Tel: [phone] 
 Camilla Hume (Nominated Advisor) 
 Michael Johnson / Julian Morse (Corporate 
  Broking) 
 
 Walbrook PR                                   Tel: [phone] or [e-mail] 
 Paul McManus / Anna Dunphy                            Mob: [phone] / Mob: [phone] 
                                                                                           741 001 
 
 

About MedaPhor (www.investors.medaphor.com)

MedaPhor (AIM: MED), the intelligent ultrasound software and simulation company, develops artificial intelligence-based clinical image analysis software tools, augmented reality-based needle guidance software and advanced hi-fidelity haptic and manikin-based training simulators for medical practitioners.

Based in Cardiff and Oxford in the UK, Atlanta in the US and Hong Kong in Asia, MedaPhor operates two divisions:

Intelligent Ultrasound Simulation Division

Focuses on hi-fidelity ultrasound education and training through simulation. Its three main products are the ScanTrainer OBGYN and General Medical simulator training platform, the HeartWorks echocardiography simulator platform and the BodyWorks Eve Point of Care and Emergency Medicine Simulator. Over 500 MedaPhor simulators have been sold to over 300 medical institutions in over 30 countries around the world.

Intelligent Ultrasound Clinical Division

Focuses on augmented reality and deep-learning based algorithms to make ultrasound machines smarter and more accessible. Products in development include ScanNav and NeedleGuide. ScanNav uses machine-learning based algorithms to automatically identify, grade and capture good ultrasound images. NeedleGuide aims to simplify ultrasound-guided needling by using deep learning and augmented reality to provide the user with pathway guidance and automated tracking for a range of medical procedures.

Some products in the pipeline may require US FDA approval, as such this material should be considered informational only and does not constitute an offer to sell or infer claims or benefits.

This information is provided by RNS

The company news service from the London Stock Exchange

END

NRALLFEAEDIVLIT

(END) Dow Jones Newswires

May 14, 2018 02:00 ET (06:00 GMT)